Filing Details
- Accession Number:
- 0001193125-17-043686
- Form Type:
- 13G Filing
- Publication Date:
- 2017-02-14 16:54:50
- Filed By:
- S&r Technology Holdings, Llc
- Company:
- Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP)
- Filing Date:
- 2017-02-14
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| S R TECHNOLOGY HOLDINGS | 0 | 0 | 0 | 0 | 0 | 0.0% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
Amendment No. 8
SUCAMPO PHARMACEUTICALS, INC.
(Name of Issuer)
CLASS A COMMON STOCK
(Title of Class of Securities)
864909106
(CUSIP Number)
DECEMBER 31, 2016
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
Check the following box if a fee is being paid with this statement. ☐
| CUSIP No.: 864909106 |
| (1) | Name of Reporting Person
S&R TECHNOLOGY HOLDINGS, LLC
I.R.S. Identification No. of Above Person
52-2242847 | |||||
| (2) | Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☐
| |||||
| (3) | SEC Use Only
| |||||
| (4) | Citizenship
DELAWARE | |||||
| Number of Shares Beneficially Owned By Each Reporting Person With | (5) | Sole Voting Power
0 | ||||
| (6) | Shared Voting Power
0 | |||||
| (7) | Sole Dispositive Power
0 | |||||
| (8) | Shared Dispositive Power
0 | |||||
| (9) | Aggregate Amount Beneficially Owned by Each Reporting Person
0 | |||||
| (10) | Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares ☐
| |||||
| (11) | Percent of Class Represented by Amount in Row (9)
0.0% | |||||
| (12) | Type of Reporting Person
OO | |||||
2
| Item 1(a). | Name of Issuer |
SUCAMPO PHARMACEUTICALS, INC.
| Item 1(b). | Address of Issuers Principal Executive Offices |
805 KING FARM BOULEVARD, SUITE 550
ROCKVILLE, MD 20850
| Item 2(a). | Name of Person Filing |
S&R TECHNOLOGY HOLDINGS, LLC
| Item 2(b). | Address of Principal Business Office or, if none, Residence |
18625 RIVER ROAD
POOLESVILLE, MD 20837
| Item 2(c). | Citizenship |
DELAWARE
| Item 2(d). | Title of Class of Securities |
CLASS A COMMON STOCK
| Item 2(e). | CUSIP No. |
864909106
| Item 3. | If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c): |
NOT APPLICABLE
| Item 4. | Ownership |
| (a) | Amount beneficially owned: |
0
| (b) | Percent of class: |
0.0%
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: |
0
3
| (ii) | Shared power to vote or to direct the vote: |
0
| (iii) | Sole power to dispose or to direct the disposition of: |
0
| (iv) | Shared power to dispose or to direct the disposition of: |
0
| Item 5. | Ownership of Five Percent or Less of a Class |
☒
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
NOT APPLICABLE
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person |
NOT APPLICABLE
| Item 8. | Identification and Classification of Members of the Group |
NOT APPLICABLE
| Item 9. | Notice of Dissolution of Group |
NOT APPLICABLE
| Item 10. | Certifications |
NOT APPLICABLE
4
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Dated: February 14, 2017 | S&R TECHNOLOGY HOLDINGS, LLC | |||||
| By: | /s/ Kei Tolliver | |||||
| Name: | Kei Tolliver | |||||
| Secretary | ||||||
5